Pitfalls of sedatives and analgesics Oversedation leads to increased duration of mechanical ventilation Longer duration of ICU stay Impede assessment of neurologic function Increase risk for delirium Numerous agent-specific adverse events Payen JF, et al. Crit Care Med. 2001;29(12):2258-2263 Adequate pain management often reduces the need for sedation 1 Reports suggest narcotic-based sedation may result in improved patient outcomes.
Pitfalls of sedatives and analgesics Oversedation leads to increased duration of mechanical ventilation Longer duration of ICU stay Impede assessment of neurologic function Increase risk for delirium Numerous agent-specific adverse events Payen JF, et al. Crit Care Med. 2001;29(12):2258-2263 Adequate pain management often reduces the need for sedation 1 Reports suggest narcotic-based sedation may result in improved patient outcomes.
Pitfalls of sedatives and analgesics Oversedation leads to increased duration of mechanical ventilation Longer duration of ICU stay Impede assessment of neurologic function Increase risk for delirium Numerous agent-specific adverse events Payen JF, et al. Crit Care Med. 2001;29(12):2258-2263 Adequate pain management often reduces the need for sedation 1 Reports suggest narcotic-based sedation may result in improved patient outcomes.
improved outcomes Leanne Boehm, MSN, RN, ACNS-BC Delirium and Cognitive Impairment Study Group Vanderbilt University Medical Center Nashville, TN USA Disclosures Hospira Need for Sedation & Analgesia Prevention of pain and anxiety Decrease oxygen consumption Decrease the stress response Patient-ventilator synchrony Avoid adverse neurocognitive sequelae Depression, PTSD Rotondi AJ, et al. Crit Care Med. 2002;30:746-52A. Weinert C, et al. Curr Opin in Crit Care. 2005;11(4):376-380. Kress JP, et al. J Respir Crit Care Med. 1996;153:1012-1018. Pitfalls of sedatives and analgesics Oversedation: Failure to initiate spontaneous breathing trials (SBT) leads to increased duration of mechanical ventilation Longer duration of ICU stay Impede assessment of neurologic function Increase risk for delirium Numerous agent-specific adverse events Kollef M, et al. Chest. 1998;114:541-548. Pandharipande, et al. Anesthesiology. 2006;124:21-26. Identifying and Treating Pain Behavioral Pain Scale (BPS) 3-12 Payen JF, et al. Crit Care Med. 2001;29(12):2258-2263. Item Description Score Facial expression Relaxed 1 Partially tightened (eg, brow lowering) 2 Fully tightened (eg, eyelid closing) 3 Grimacing 4 Upper limbs No movement 1 Partially bent 2 Fully bent with finger flexion 3 Permanently retracted 4 Compliance with ventilation Tolerating movement 1 Coughing but tolerating ventilation for most of the time 2 Fighting ventilator 3 Unable to control ventilation 4 A note on pain control Pain can cause agitation and lead to excessive use of sedatives Adequate pain management often reduces the need for sedation 1 Reports suggest narcotic-based sedation may result in improved patient outcomes 2-3
1 Kress JP et al, AJRCCM 2002; 168(8): 1024-8 2 Breen D et al, Crit Car 2005; 9(3): R200-10 3 Pandharipande P & Ely EW, Crit Car 2005; 9(3): 247-8 Analgosedation Analgesia-first sedation & sedative if needed Increasingly used in many countries Acknowledges discomfort as a cause of agitation Usually continuous infusion 30-74% required benzodiazepine/propofol rescue Study of remifentanil vs midazolam sedation Reduction in vent time (2 d) and ICU LOS (1d) Not appropriate for drug or alcohol withdrawal Dahaba AA, et al. Anesthesiology. 2004;101:640-646. Park G, et al. Br J Anaesth. 2007;98:76-82. Rozendall FW, et al. Intensive Care Med. 2009;35:291-298. Strm T, et al. Lancet. 2010;375(9713):475-480 Sedation assessment and maintaining a sedation goal Sedation Scales Pun & Dunn, AJN 2007; 107(7):40-48 Richmond Agitation Sedation Scale (RASS) Score State + 4 Combative + 3 Very agitated + 2 Agitated + 1 Restless 0 Alert and calm -1 Drowsy eye contact > 10 sec -2 Light sedation eye contact < 10 sec -3 Moderate sedation no eye contact -4 Deep sedation physical stimulation -5 Unarousable no response even with physical Ely EW, et al. JAMA. 2003;289(22):2983-2991. Sessler CN, et al. Am J Respir Crit Care Med. 2002;166(10):1338-1344. Verbal Stimulus Physical Stimulus ICU Sedation: The Balancing Act Oversedation Patient Comfort and Ventilatory Optimization G O A L Undersedation Patient recall Device removal Ineffectual mechanical ventilation Initiation of neuromuscular blockade Myocardial or cerebral ischemia Decreased family satisfaction w/ care Severe discomfort Hypertension Tachycardia Increased ICP Increase metabolic demand Delirium
Prolonged mechanical ventilation Increase length of stay Increased risk of complications (I.e. VAP) Increased diagnostic testing Inability to evaluate for delirium Cardio/respiratory depression Decreased GI motility Immunosuppression Delirium Jacobi J, et al. CCM. 2002;30:119-141 Carrasco G. Crit Care. 2000;4:217-225 McGaffigan PA. CCN. 2002;Feb(suppl):29-36 Blanchard AR. Postgrad Med. 2002;111:59-74 ASHP Therapeutic Guidelines. Best Practices for Health-System Pharmacy. 2003-2004;486-512 Setting Targets 1 Bekker AY, et al. Neurosurgery 2005;57(1 Suppl 1):1-10 Aim for Cooperative: Calm & Easily Arousable State while minimizing pain, anxiety, or agitation unless contraindicated Easy transition from sleep to wakefulness 1
Can participate in weaning and physical therapy 1
Perform therapeutic maneuvers Able to perform a cognitive evaluation
Adjust depending on patient need Over the course of Illness/Treatment Initial Intubation vs Stabilization Weaning Phase The importance of preventing and identifying delirium What is delirium? Common clinical syndrome that is characterized by: Inattention Acute cognitive dysfunction
Thought to be due to disruption of neurotransmission related to: Drug toxicity Inflammation Acute stress responses Delirium Morandi, A et al., ICM 2009;34:1907-15 Prevalence of Delirium in the ICU 6080% MICU/SICU/TICU ventilated patients develop delirium 2050% of lower severity ICU patients develop delirium Majority goes undiagnosed if routine monitoring is not implemented Hypoactive or mixed forms most common Ouimet S, et al. Intensive Care Med. 2007;33:66-73 Ely EW, et al. JAMA. 2001;286,2703-2710 Pandharipande PP, et al. J Trauma. 2008;65:34-41 Ely EW, et al. Intensive Care Med. 2001;27:1892-1900. Dubois MJ, et al. Intensive Care Med 2001;27:1297-1304 Patient Factors Increased age Alcohol use Male gender Living alone Smoking Renal disease Depression Vision/Hearing impaired Environment Admission via ED or through transfer Isolation No clock No daylight No visitors Noise Use of physical restraints Sleep deprivation Predisposing Disease Cardiac disease Cognitive impairment (eg, dementia) Pulmonary disease HIV
Acute Illness Length of stay Fever Medicine service Lack of nutrition Hypotension Sepsis Metabolic disorders Tubes/catheters Medications: - Anticholinergics - Corticosteroids - Benzodiazepines
Less Modifiable More Modifiable DELIRIUM Inouye SK, et al. JAMA .1996;275:852. Van Rompaey B, et al. Crit Care 2009;13:R77. Skrobik Y. Crit Care Clin. 2009;25(3):585-591. Devlin J, et al. ICM, 2007; 33:929-940. After Hospital Discharge During the ICU/Hospital Stay Sequelae of Delirium - Increased mortality - 3x greater re-intubation rate - Average 10 additional days in hospital - Higher costs of care - Increased mortality - Long-term cognitive impairment - D/c requirement for chronic care facility - Decreased functional status at 6 months
Milbrandt EB, et al. Crit Care Med. 2004;32:955-962. Nelson JE, et al. Arch Intern Med. 2006;166:1993-1999. Ely EW, et al. JAMA. 2004;291:1753-1762. Jackson JC, et al. Neuropsychol Rev. 2004;14(2):87-98. Intensive Care Delirium Screening Checklist 1. Altered level of consciousness 2. Inattention 3. Disorientation 4. Hallucinations 5. Psychomotor agitation or retardation 6. Inappropriate speech 7. Sleep/wake cycle disturbances 8. Symptom fluctuation Bergeron N, et al. Intensive Care Med. 2001;27:859-864. Ouimet S, et al. Intensive Care Med. 2007;33:1007-1013. Score 1 point for each component present during shift Score of 1-3 = Subsyndromal Delirium Score of 4 = Delirium Confusion Assessment Method (CAM-ICU) or 3. Altered level of consciousness 4. Disorganized thinking = Delirium Ely EW, et al. Crit Care Med. 2001;29:1370-1379. Ely EW, et al. JAMA. 2001;286:2703-2710. 1. Acute onset of mental status changes or a fluctuating course 2. Inattention and and Feature 1: Alteration/Fluctuation in Mental Status Is the pt different than his/her baseline mental status? OR Has the patient had any fluctuation in mental status in the past 24 hours (eg fluctuating RASS, GCS, previous delirium assessments, etc)? Positive/Present: If either question is YES.
Feature 2: Inattention Attention Screening Exam
Auditory: Letter A Say 10 letters & tell patient to squeeze on A Letters: S A V E A H A A R T Scoring: Count error if patient fails to squeeze on A and when they squeeze on any letter other than A
Visual: Pictures Similar to letters but with pictures Positive/Present: If score is <8
Feature 4: Alt Level of Consciousness
Any LOC other than Alert.
Positive/Present: If the Actual RASS score is anything other than 0 Feature 3: Disorganized Thinking A: Yes/No Questions 1. Will a stone float on water? 2. Are there fish in the sea? 3. Does one pound weigh more than two pounds? 4. Can you use a hammer to pound a nail?
B: Command Say to patient: Hold up this many fingers (Examiner holds two fingers in front of patient) Now do the same thing with the other hand (Not repeating the number of fingers).
Positive/Present: If combined score (questions + command) is less than 4 If sedation is required, what is the optimal sedative choice? Characteristics of an Ideal Sedative Rapid onset of action allows rapid recovery after d/c 1
Effective at providing adequate sedation with predictable dose response 1,2
Easy to administer 1,3
Lack of drug accumulation 1
Few adverse effects 1-3
Minimal adverse interactions with other drugs 1-3
Cost-effective 3 Promotes natural sleep 4 1. Ostermann ME, et al. JAMA. 2000;283:1451-1459. 2. Jacobi J, et al. Crit Care Med. 2002;30(1):119-141. 3. Dasta JF, et al. Pharmacother. 2006;26:798-805. 4. Nelson LE, et al. Anesthesiol. 2003;98:428-436. Choice of Sedatives Benzodiazepines GABA A receptor modulation in CNS Facilitates binding of GABA Hyperpolarize cells, making them more resistant to excitation Propofol Not well understood GABA receptor modulation is likely Dexmedetomidine 2-adrenergic agonist (inhibits NE release in CNS & PNS) CNS: sedation/hypnosis, anxiolysis, and analgesia PNS: decreases BP and HR; activates endogenous sleep-promoting pathway No respiratory suppression Enables cognitive evaluation & patient communication Consider Comorbidities When Choosing a Sedation Regimen Chronic pain Organ dysfunction CV instability Substance withdrawal Respiratory insufficiency Obesity Obstructive sleep apnea Risk of delirium with benzodiazepines Pandharipande P, et al. J Trauma. 2008; 65:34-41. Pandharipande P, et al. Anesthesiol. 2006:104:21-26. Randomized Trial ICU Comparato r Superior Ronan et al.1995 Surgical Midazolam Propofol Chamorro et al. 1996 General Midazolam Propofol Hsiao et al. 1996 Surgical Midazolam Equivalen t Kress et al. 1996 Medical Midazolam Propofol Barrientos-Vega et al. 1997 General Midazolam Propofol Searle et al. 1997 Cardiac Midazolam Equivalen t Weinbroum et al. 1997 General Midazolam Both Sanchez-Izquierdo-Riera JA, et al. 1998 Trauma Midazolam Superior Hall et al. 2001 Mixed Midazolam Propofol Carson et al. 2006 Medical Lorazepam Propofol Propofol vs benzodiazepines Outcomes improved by propofol: sedation quality, ventilator synchrony, time to awakening, variability of awakening, time to extubation from discontinuation of sedation, overall time to extubation, ventilator days, ICU LOS among survivors, costs of sedation MENDS MICU/SICU Patients Ventilated & Sedated N=103 Control Lorazepam (GABA) Fentanyl Intervention Dexmedetomidine (2) Fentanyl Pandharipande PP, et al. JAMA 2007;298:2644-53 Double-blind RCT of dexmedetomidine vs lorazepam infusion Intervention: Dexmedetomidine 0.151.5 mcg/kg/hr Lorazepam infusion 110mg/hr No daily interruption, patient targeted sedation MENDS: dexmedetomidine vs lorazepam Pandharipande P et al JAMA, 2007; 298:2644-2653 Dexmedetomidine resulted in: More days alive without delirium or coma (p=.01) Lower prevalence of coma (p=.001) More time spent within sedation goals (p=.04) Differences in 28-day mortality and delirium-free days were not significant SEDCOM MICU Patients Ventilated & Sedated n=366 Control Midazolam (GABA) Fentanyl Intervention Dexmedetomidine (2) Fentanyl Riker, R., et al. JAMA 2009; 301(5): 489-499 Double-blind, RCT comparing long-term dexmedetomidine vs midazolam Sedatives (dex 0.2-1.4 g/kg/hr or midaz 0.02-0.1 mg/kg/hr) titrated for light sedation, administered up to 30 days Daily arousal assessments and drug titration Q4h SEDCOM: dexmedetomidine vs midazolam Dexmedetomidine resulted in: less time on the ventilator (p=.01) less delirium (p<.001) less tachycardia (p<.001) less hypertension (p=.02) Most notable adverse effect of dexmedetomidine was bradycardia (p<.001)
Strategies to Reduce the Duration of Mechanical Ventilation in Patients Receiving Continuous Sedation Daily sedation interruption decreases days of MV Hold infusion until patient awake, then restart at 50% of prior dose Awake defined as 3 of the following 4: Open eyes in response to voice Use eyes to follow investigator on request Squeeze hand on request Stick out tongue on request Kress JP, et al. N Engl J Med. 2000;342:1471-1477. Fewer diagnostic tests to assess changes in mental status No increase in rate of agitated-related complications or episodes of patient-initiated device removal No increase in PTSD or cardiac ischemia The ABC Trial (both groups get patient targeted sedation) OUTCOMES delirium, LOS, 12-mo NPS testing, QOL Spontaneous Breathing Trial (SBT) ventilator off safely monitored OUTCOMES delirium, LOS, 12-mo NPS testing, QOL Spontaneous Breathing Trial (SBT) ventilator off safely monitored Spontaneous Awakening Trial (SAT) turn sedation/narcotics off monitor safely Medical ICU on Ventilator Surrogate Informed Consent Control Intervention Girard TD, et al. Lancet. 2008;371:126-134. The ABC Trial SBT+usual care vs SAT+SBT Patients in the intervention group: Less time in coma (p=.002) 2 days less on the ventilator (p=.02) 4 days less in the ICU (p=.02) 4 days less in the hospital (p=.04) Less exposure to benzodiazepines Were more likely to be alive in 1 year (p=.01) More self extubations, but not more reintubations Girard TD, et al. Lancet. 2008;371:126-134. Early Mobilization Schweickert et al, Lancet 2009;373:1874-82 Mobility A fundamental nursing activity Enhances gas exchange Reduces VAP rates Shortened duration of MV Enhances long-term functional ability Schweickert WD, et al. Lancet. 2009;373:1874-1882. 24% improvement (1.7-fold better) return to independent functional status at discharge (NNT=4) Daily Wake-Up + Early Mobility
Outcome Intervention (n=49) Control (n=50)
P Functionally independent at discharge 29 (59%) 19 (35%) .02 ICU delirium (days) 2.0 (0.0-6.0) 4.0 (2.0-7.0) .03 Time in ICU with delirium (%) 33% (0-58) 57% (33-69) .02 Hospital delirium (days) 2.0 (0.0-6.0) 4.0 (2.0-8.0) .02 Hospital days with delirium (%) 28% (26) 41% (27) .01 Barthel Index score at discharge 75 (7.5-95) 55 (0-85) .05 ICU-acquired paresis at discharge 15 (31%) 27 (49%) .09 Ventilator-free days 23.5 (7.4-25.6) 21.1 (0.0-23.8) .05 Length of stay in ICU (days) 5.9 (4.5-13.2) 7.9 (6.1-12.9) .08 Length of stay in hospital (days) 13.5 (8.0-23.1) 12.9 (8.9-19.8) .93 Hospital mortality 9 (18%) 14 (25%) .53 Schweickert WD, et al. Lancet. 2009;373:1874-1882. Implementation challenges Many issues to address Multiple disciplines are involved RN, RT, MD, PT/OT, pharmacist Timing Coordination, collaboration, & teamwork Protocol development Change in culture of workplace Costs Resistance to change Putting it all together Clinical case Male patient, age 74 Hx: Dementia, coronary artery disease, diabetes, hypertension CC: altered mental status, shortness of breath Currently hypoxic and required MV Dx: Septic shock, ARDS, acute renal failure Clinical case Current vent settings: A/C 16, TV 400, PEEP 14, FiO2 80% Current infusions: norepinephrine 10 mcg/min, vasopressin 0.4 units/min, insulin gtt, IVF Assessment: Target RASS -4, actual RASS +1 to -1, displaying vent asynchrony, CAM-ICU positive, bilat rhonchi, pulses present Receiving intermittent boluses of fentanyl and lorazepam Nursing interventions? Clinical case Current vent settings: A/C 16, TV 400, PEEP 5, FiO2 40% Current infusions: propofol 40 mcg/kg/hr, norepinephrine 4 mcg/min, vasopressin 0.4 units/min, insulin gtt, IVF Intermittent fentanyl for analgesia Assessment: Target RASS -1, actual RASS -3, CAM-ICU positive, not breathing over vent set rate, bilat rhonchi, pulses present, moving extremities spontaneously Nursing interventions: for sedation? for delirium? (pharm/nonpharm) Clinical case Current vent settings: PS 5, PEEP 5, FiO2 40%, RR 22 Current infusions: Norepinephrine/vasopressin off, insulin gtt, IVF, propofol off Septic shock resolved, passed SAT/SBT Assessment: Target RASS 0, actual RASS 0, CAM-ICU positive, lungs clear, moves all extremities Nursing interventions: for sedation? for delirium? (pharm/nonpharm)
Clinical Case What if the patient had not passed the SBT and was beginning to become agitated? Would you consider pharmacologic treatment for delirium at this point? What if we extubated this patient and he later became agitated?
Summary Goals for sedation: Are we on the same page? Daily Sedation Cessation: Did you wake up your patient today? Sedative Choice: What is the best option for my patient right now? Roadmap: How do we put it all together at the bedside? Educational Delirium Website